Benzinga's Top Initiations

Analysts at Cantor Fitzgerald initiated coverage on Ross Stores, Inc. ROST with a Hold rating. The target price for Ross Stores is set to $110. Ross Stores' shares closed at $102.29 yesterday. Analysts at Wunderlich initiated coverage on Jernigan Capital Inc. JCAP with a Buy rating. The target price for Jernigan Capital is set to $25. Jernigan Capital's shares closed at $21.30 yesterday. Analysts at FBR Capital initiated coverage on Regulus Therapeutics Inc RGLS with a Outperform rating. The target price for Regulus Therapeutics is set to $30. Regulus Therapeutics' shares closed at $17.18 yesterday. Stifel Nicolaus initiated coverage on Summit Materials Inc SUM with a Buy rating. The target price for Summit Materials is set to $28. Summit Materials' shares closed at $24.22 yesterday. FBR Capital initiated coverage on Genocea Biosciences Inc GNCA with a Outperform rating. The target price for Genocea Biosciences is set to $20. Genocea Biosciences' shares closed at $12.93 yesterday. Analysts at FBR Capital initiated coverage on Zafgen Inc ZFGN with a Outperform rating. The target price for Zafgen is set to $60. Zafgen's shares closed at $36.58 yesterday. Raymond James initiated coverage on Community Bank System, Inc. CBU with a Market Perform rating. Community Bank System's shares closed at $35.64 yesterday. Analysts at FBR Capital initiated coverage on Biocryst Pharmaceuticals, Inc. BCRX with a Outperform rating. The target price for Biocryst Pharmaceuticals is set to $18. Biocryst Pharmaceuticals' shares closed at $10.29 yesterday. FBR Capital initiated coverage on Corcept Therapeutics Incorporated CORT with a Outperform rating. The target price for Corcept Therapeutics is set to $12. Corcept Therapeutics' shares closed at $5.98 yesterday.